Clinical Trial Update: Study on VCD/IE in the Patients With Ewing's Sarcoma Family of Tumors (ESFT) [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating the VCD/IE regimen in patients with Ewing's sarcoma family tumors has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Ewing Sarcoma

Drugs mentioned

• CYCLOPHOSPHAMIDE (Cyclophosphamide)
• Doxorubicin (doxorubicin)
• Etoposide (Etoposide)
• IFOSFAMIDE (IFOSFAMIDE)
• Vincristine (vincristine)

Snippet

Sponsor: Fudan University | Conditions: Ewing's Sarcoma | Phase 2 | Status: TERMINATED